FindTrial
Sign In

Investigation on the assocition between atopic dermatitis and obesity

Clinical study on the gut microbiome-metabolome-immune characteristics of atopic dermatitis according to obesity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003630
Enrollment
80
Registered
2019-03-18
Start date
2018-12-15
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Wonkwang University. Iksan Korean Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Boys or girls aged 4 to 12 years old. -BMI at or above the 85th percentile, or at or below the 25th percentile in the same age and sex group. -Subjects who can follow the dietary guidelines for 3 days. -Subjects who agree to participate and voluntarily sign a written informed consent.

Exclusion criteria

Exclusion criteria: -Subjects with severe skin disease or systemic disease. -Use of oral antibiotics, corticosteroids, anti-histamines, or immunosuppressive drugs within the last 4 weeks. -Use of prebiotics, probiotics, or herbal medicine within the last 4 weeks. -Subjects who are expected to defecate abnormally during the study period because of constipation. -Any subject considered unsuitable for participation in the study by the investigator.

Design outcomes

Primary

MeasureTime frame
SCORing of Atopic Dermatitis (SCORAD index)—

Secondary

MeasureTime frame
Children’s Dermatology Life Quality Index (CDLQI);Korean Gastrointestinal Symptom Rating Scale;Body Composition Analysis;Microbiome analysis;metabolome biomarker;Immune biomarker—

Countries

Korea, Republic of

Contacts

Public ContactMin Cheol Park

Wonkwang University. Iksan Korean Medicine Hospital

spinx11@gmail.com+82-63-859-2821

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 21, 2026